First human demonstration of cardiac stimulation with transcutaneous ultrasound energy delivery: implications for wireless pacing with implantable devices.

[1]  R. E. Riley,et al.  Feasibility and safety of a novel technology for pacing without leads. , 2006, Heart rhythm.

[2]  Jeroen J. Bax,et al.  Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questions. , 2005, Journal of the American College of Cardiology.

[3]  D. Kass,et al.  Cardiac Resynchronization Therapy , 2007, Mayo Clinic Cardiology.

[4]  Arjun D. Sharma,et al.  Percent right ventricular pacing predicts outcomes in the DAVID trial. , 2005, Heart rhythm.

[5]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[6]  S. Bornstein,et al.  Images in clinical medicine. Obstructive lingual thyroid. , 2005, New England Journal of Medicine.

[7]  Paolo Rizzon,et al.  Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchronization therapy. , 2005, Journal of the American College of Cardiology.

[8]  Atul Verma,et al.  Intravascular pacemaker and defibrillator lead extraction: a state-of-the-art review. , 2004, Heart rhythm.

[9]  Lisa Hartling,et al.  Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure , 2004, Annals of Internal Medicine.

[10]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[11]  A. Auricchio,et al.  Cardiac resynchronization therapy: current state of the art: cost versus benefit. , 2004, Circulation.

[12]  S. Kutalek.  Pacemaker and defibrillator lead extraction , 2004, Current opinion in cardiology.

[13]  K. Ellenbogen,et al.  Resynchronization Therapy for the Treatment of Heart Failure , 2003, Circulation.

[14]  G. Lamas,et al.  Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction , 2003, Circulation.

[15]  S. Connolly,et al.  Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. CTOPP Investigators. , 2001, Journal of the American College of Cardiology.

[16]  L. Goldman,et al.  Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. , 1998, Pacing and clinical electrophysiology : PACE.

[17]  A. Camm,et al.  The United Kingdom pacing and cardiovascular events (UKPACE) trial. United Kingdom Pacing and Cardiovascular Events. , 1997, Heart.

[18]  O. Soykan.  Automated piecewise linear modelling of pacing leads , 1994, Proceedings of 16th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[19]  R. Phillips.  Guidance for Industry and FDA Staff Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers , 2008 .

[20]  L. Warner Stevenson.  The points for pacing. , 2003, Journal of the American College of Cardiology.

[21]  P. Wells.  Biomedical Ultrasonics , 1977 .